159 related articles for article (PubMed ID: 32088829)
1. Drug synergy as a strategy for compression of morbidity in a Caenorhabditis elegans model of Alzheimer's disease.
Teo E; Fong S; Tolwinski N; Gruber J
Geroscience; 2020 Jun; 42(3):849-856. PubMed ID: 32088829
[TBL] [Abstract][Full Text] [Related]
2. Metabolic stress is a primary pathogenic event in transgenic
Teo E; Ravi S; Barardo D; Kim HS; Fong S; Cazenave-Gassiot A; Tan TY; Ching J; Kovalik JP; Wenk MR; Gunawan R; Moore PK; Halliwell B; Tolwinski N; Gruber J
Elife; 2019 Oct; 8():. PubMed ID: 31610847
[TBL] [Abstract][Full Text] [Related]
3. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol reduces amyloid-beta (Aβ₁₋₄₂)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans.
Regitz C; Fitzenberger E; Mahn FL; Dußling LM; Wenzel U
Eur J Nutr; 2016 Mar; 55(2):741-747. PubMed ID: 25851110
[TBL] [Abstract][Full Text] [Related]
5. Cranberry Extract Standardized for Proanthocyanidins Alleviates β-Amyloid Peptide Toxicity by Improving Proteostasis Through HSF-1 in Caenorhabditis elegans Model of Alzheimer's Disease.
Guo H; Cao M; Zou S; Ye B; Dong Y
J Gerontol A Biol Sci Med Sci; 2016 Dec; 71(12):1564-1573. PubMed ID: 26405062
[TBL] [Abstract][Full Text] [Related]
6. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
Wang C; Saar V; Leung KL; Chen L; Wong G
Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of Coptis chinensis Franch polysaccharide on amyloid-beta (Aβ)-induced toxicity in a transgenic Caenorhabditis elegans model of Alzheimer's disease (AD).
Li Y; Guan S; Liu C; Chen X; Zhu Y; Xie Y; Wang J; Ji X; Li L; Li Z; Zhang Y; Zeng X; Li M
Int J Biol Macromol; 2018 Jul; 113():991-995. PubMed ID: 29524490
[TBL] [Abstract][Full Text] [Related]
8. rBTI reduced β-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
Li J; Cui X; Ma X; Wang Z
Exp Gerontol; 2017 Mar; 89():78-86. PubMed ID: 28119052
[TBL] [Abstract][Full Text] [Related]
9. Mitoferrin-1 is Involved in the Progression of Alzheimer's Disease Through Targeting Mitochondrial Iron Metabolism in a Caenorhabditis elegans Model of Alzheimer's Disease.
Huang J; Chen S; Hu L; Niu H; Sun Q; Li W; Tan G; Li J; Jin L; Lyu J; Zhou H
Neuroscience; 2018 Aug; 385():90-101. PubMed ID: 29908215
[TBL] [Abstract][Full Text] [Related]
10. Ingredients in Zijuan Pu'er Tea Extract Alleviate β-Amyloid Peptide Toxicity in a
Du F; Zhou L; Jiao Y; Bai S; Wang L; Ma J; Fu X
Molecules; 2019 Feb; 24(4):. PubMed ID: 30781621
[TBL] [Abstract][Full Text] [Related]
11. A deuterohemin peptide protects a transgenic Caenorhabditis elegans model of Alzheimer's disease by inhibiting Aβ
Xu J; Yuan Y; Zhang R; Song Y; Sui T; Wang J; Wang C; Chen Y; Guan S; Wang L
Bioorg Chem; 2019 Feb; 82():332-339. PubMed ID: 30428413
[TBL] [Abstract][Full Text] [Related]
12. Monascin from Monascus-Fermented Products Reduces Oxidative Stress and Amyloid-β Toxicity via DAF-16/FOXO in Caenorhabditis elegans.
Shi YC; Pan TM; Liao VH
J Agric Food Chem; 2016 Sep; 64(38):7114-20. PubMed ID: 27554775
[TBL] [Abstract][Full Text] [Related]
13. Tire components, age and temperature accelerate neurodegeneration in C. elegans models of Alzheimer's and Parkinson's disease.
Limke A; Scharpf I; Blesing F; von Mikecz A
Environ Pollut; 2023 Jul; 328():121660. PubMed ID: 37080524
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
Regitz C; Dußling LM; Wenzel U
Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
[TBL] [Abstract][Full Text] [Related]
15. 18α-Glycyrrhetinic Acid Proteasome Activator Decelerates Aging and Alzheimer's Disease Progression in Caenorhabditis elegans and Neuronal Cultures.
Papaevgeniou N; Sakellari M; Jha S; Tavernarakis N; Holmberg CI; Gonos ES; Chondrogianni N
Antioxid Redox Signal; 2016 Dec; 25(16):855-869. PubMed ID: 26886723
[TBL] [Abstract][Full Text] [Related]
16. Testing the amyloid toxicity hypothesis of Alzheimer's disease in transgenic Caenorhabditis elegans model.
Gutierrez-Zepeda A; Luo Y
Front Biosci; 2004 Sep; 9():3333-8. PubMed ID: 15353361
[TBL] [Abstract][Full Text] [Related]
17. N-butanol extract of Hedyotis diffusa protects transgenic Caenorhabditis elegans from Aβ-induced toxicity.
DanQing L; YuJie G; ChengPeng Z; HongZhi D; Yi H; BiSheng H; Yan C
Phytother Res; 2021 Feb; 35(2):1048-1061. PubMed ID: 32924204
[TBL] [Abstract][Full Text] [Related]
18. Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model.
Kumar J; Park KC; Awasthi A; Prasad B
CNS Neurol Disord Drug Targets; 2015; 14(2):295-302. PubMed ID: 25613505
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan inhibits amyloid-β-induced toxicity in transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-β and decreasing the production of reactive oxygen species.
Wang X; Yi K; Zhao Y
Food Funct; 2018 Jan; 9(1):552-560. PubMed ID: 29260173
[TBL] [Abstract][Full Text] [Related]
20. Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease.
Godini R; Pocock R; Fallahi H
PLoS One; 2019; 14(7):e0219486. PubMed ID: 31291334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
